Dr Michelle Magee is the Vice President of Clinical Projects at Redenlab. She is responsible for overseeing our clinical project management and data analytic teams and ensuring smooth cross-functional conduct for sponsored trials. Michelle holds a PhD from The University of Melbourne and has over 10 years’ experience in managing and delivery clinical trial operations in both academic and CRO environments. Prior to joining Redenlab Michelle worked as a Research Fellow at the University of Melbourne with expertise in physiological biomarker research.